Angel Matthew
- SEC CIK
- 0001931356
In the past year, 1 open-market purchase filing worth $500.0K and no sales.
Current role at each company
- TPST Tempest Therapeutics, Inc.CEO and Presidentas of Jun 23, 2026
- ERNA Ernexa Therapeutics Inc.President and CEOas of Jan 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $500.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$500.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Angel Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TPST Tempest Therapeutics, Inc.
CEO and President3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 (view filing) | Mar 24 | 91 daysLate | Angel MatthewCEO and President | PPurchase | +231.5K | $2.16 | +$500.0K | New position231.5K after | Duplicate filing |
| Jun 23, 2026 (view filing) | Mar 24 | 91 daysLate | Angel MatthewCEO and President | PPurchase | +463.0K | – | – | –231.5K after | Derivative2 lots |
| Mar 25, 2026 (view filing) | Mar 24 | 1 day | Angel MatthewCEO and President | PPurchase | +231.5K | $2.16 | +$500.0K | New position231.5K after |